FDA
-
-
-
-
-
-
-
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
-
-
-
-
-
-
-
BioVersys BV100 Phase 2b to be Conducted Via Wellcome Funded Trial Network
-
-
-
-
-
-
-
BioVaxys Expands Cancer Vaccine Platform
-
-
-
-
-
-
-
BIOVAXYS files FDA pre-IND meeting request and briefing package for COVID-T
-
-
-
-
-
-
322,968 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

